CoronaVac phase 3 trial : Sinovac Biotech, a Chinese biopharma company has secured approval in Brazil to begin a phase 3 clinical trial for CoronaVac, its inactivated COVID-19 vaccine candidate. Brazil is currently the second most infected country after the US with the novel coronavirus. The Chinese pharma company has been granted the approval by […]
Sinovac Biotech said that the phase 1/2 clinical trial for its coronavirus vaccine candidate CoronaVac has delivered positive preliminary results by showing favorable immunogenicity and safety profiles. According to the Chinese biopharma company, the phase 1/2 clinical trials are randomized, double-blind and placebo-controlled studies featuring 743 healthy volunteers, aged between 18 and 59 years. Of […]
SARS-CoV-2 vaccine trial : Chinese biopharma company Sinovac Biotech has started a phase 1 clinical trial for SARS-CoV-2 vaccine, its COVID-19 vaccine candidate in 144 healthy adults, aged between 18 and 59. Sinovac Biotech had recently secured approval from China’s National Medical Products Administration (NMPA) to launch the randomized, double-blinded, placebo-controlled study for the coronavirus […]
Coronavirus vaccine trial : Chinese biopharma company Sinovac Biotech has secured approval to carry out a human clinical trial on an inactivated COVID-19 vaccine candidate, which it had been developing since late January. The company said that its scientists have quickly wrapped up comprehensive preclinical studies in collaboration with some of the top academic research […]